Recent Research | Page 72 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journalsort ascending Bone Marrow Disease
A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data Jan 2015 Ann Lab Med paroxysmal nocturnal hemoglobinuria (PNH)
A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. Apr 2012 Ann Hematol. aplastic anemia
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis Feb 2015 Ann Hematol aplastic anemia
Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine. Jun 2013 Ann Hematol myelodysplastic syndromes (MDS)
Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide May 2014 Ann Hematol myelodysplastic syndromes (MDS)
Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II Nov 2016 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol Aug 2016 Ann Hematol myelodysplastic syndromes (MDS)
Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents? Oct 2015 Ann Hematol myelodysplastic syndromes (MDS)
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes. Sep 2013 Ann Hematol myelodysplastic syndromes (MDS)
Multiparameter FLAER-based flow cytometry for screening of paroxysmal nocturnal hemoglobinuria enhances detection rates in patients with aplastic anemia Dec 2014 Ann Hematol aplastic anemia